Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1, TRIP13)

A high prevalence of antinuclear antibodies (ANA) in COVID-19 has been insinuated, but the nature of the target antigens is poorly understood. We studied ANA by indirect immunofluorescence in 229 individuals with COVID-19. The target antigens of high titer ANA (≥1:320) were determined by immunopreci...

Descripción completa

Detalles Bibliográficos
Autores principales: Bossuyt, Xavier, Vulsteke, Jean-Baptiste, Van Elslande, Jan, Boon, Lise, Wuyts, Greet, Willebrords, Silke, Frans, Glynis, Geukens, Nick, Carpentier, Sebastien, Tejpar, Sabine, Wildiers, Hans, Blockmans, Daniel, De Langhe, Ellen, Vermeersch, Pieter, Derua, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893804/
https://www.ncbi.nlm.nih.gov/pubmed/36738952
http://dx.doi.org/10.1016/j.autrev.2023.103288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893804/
https://www.ncbi.nlm.nih.gov/pubmed/36738952
http://dx.doi.org/10.1016/j.autrev.2023.103288

Ejemplares similares